Diabetes prevalence is set to grow by 48 percent over the next 25 years – so where does that leave ophthalmologists?
What does the future hold for the management – and treatment – of diabetic eye disease?
The winners of the ICO-Allergan Advanced Research Fellowship… in conversation.
Could an FDA-approved asthma medication offer a therapeutic pathway for diabetic retinopathy?
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
The Power List is Here!
Recharging After Long COVID